PEOClass II
Fungal Organisms, Nucleic Acid-Based Assay
21 CFR 866.3365 / Microbiology
PEO is the FDA product code for Fungal Organisms, Nucleic Acid-Based Assay, a class II device type, regulated under 21 CFR 866.3365. FDA's definition for this code reads: "A qualitative multiplexed in vitro diagnostic device to detect and identify fungal organisms in positive blood cultures". As of , FDA records hold 2 510(k) clearances under this code, the most recent dated , and no recalls.
Classification record
- Product code
- PEO
- Device name
- Fungal Organisms, Nucleic Acid-Based Assay
- FDA definition
- A qualitative multiplexed in vitro diagnostic device to detect and identify fungal organisms in positive blood cultures.
- Regulation
- 21 CFR 866.3365
- Device class
- Class II
- Review panel
- Microbiology
- Submission type
- 510(k)
- Implant
- No
- Life sustaining or supporting
- No
- GMP exempt
- No
- Third party review eligible
- No
- Ingested clearances
- 2
- Ingested recalls
- 0
Clearances, product code PEO
By decision yearShow the numbers
| Year | Clearances |
|---|---|
| 2018 | 1 |
| 2024 | 1 |
Applicants with the most clearances
Product code PEO| Applicant | Clearances |
|---|---|
| Genmark Diagnostics, Incorporated | 1 |
| Luminex Corporation | 1 |
Companies listing this code with FDA
Companies whose registered establishments list this codeFIRST ARTICLE / WEEKLY
What cleared, what was recalled, and what changed in the standards. One edition a week for the people who make medical devices.
